Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Factors influencing the association between CYP17 T34C polymorphism and the risk of breast cancer: meta-regression and subgroup analysis.

Breast cancer research and treatment - 1 Jul 2010

Chen Yun, Pei Jianping

Abstract excerpt

A number of studies have been investigated the association between CYP17 T34C polymorphism and the risk of breast cancer; the results of these studies are inconsistent, however. This fact implies that the effect of CYP17 T34C polymorphism on susceptibility to breast cancer may be modified by other risk factors. In order to provide a more definitive conclusion, a full meta-analysis combining and summarizing 24...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Age Factors
Share to Bayes Theorem
Share to Body Mass Index

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Odds Ratio

Share to Postmenopause

Share to Premenopause

Share to Risk Assessment

Share to Steroid 17-alpha-Hydroxylase

Source

Identifiers

PMID: 20043206
DOI: 10.1007/s10549-009-0690-9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Factors influencing the association between CYP17 T34C polymorphism and the risk of breast cancer: meta-regression and subgroup analysis.PMID 20043206Read ↗

No association between CYP17 T-34C polymorphism and breast cancer risk: a meta-analysis involving 58,814 subjects.Semantic proximity Read ↗

CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors: Australian Breast Cancer Family Study.Semantic proximity Read ↗

CYP17 gene polymorphism in relation to breast cancer risk: a case-control study.Semantic proximity Read ↗

Correlations between CYP3A4 polymorphism and susceptibility to breast cancer in Chinese Han population.Semantic proximity Read ↗

Lack of significant association between CYP1A1 T3801C polymorphism and breast cancer risk: a meta-analysis involving 25,087 subjects.Semantic proximity Read ↗

Analysis of CYP17, CYP19 and CYP1A1 Gene Polymorphisms in Iranian Women with Breast Cancer.Semantic proximity Read ↗

The CYP17A1 -34T > C polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

The CYP17 MspA1 polymorphism and breast cancer risk: a meta-analysis.Semantic proximity Read ↗

MTHFR C677T polymorphism associated with breast cancer susceptibility: a meta-analysis involving 15,260 cases and 20,411 controls.Semantic proximity Read ↗

Postmenopausal estrogen monotherapy-associated breast cancer risk is modified by CYP17A1_-34_T>C polymorphism.Semantic proximity Read ↗

Genetic variation of the CYP17 and susceptibility to endometrial cancer: a meta-analysis.Semantic proximity Read ↗

[Study on the association between CYP24A1 genetic polymorphisms and risks related to postmenopausal breast cancer].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.